Olink Explore - The promise of proteomics
5 Dec 2019
This video introduces Olink Explore, which enables scientists to measure 1536 proteins simultaneously using just 3 µL of human plasma or serum. This new protein biomarker solution retains the unparalled specificity & sensitivity of the Olink Proximity Extension Assay (PEA) technology, with readout on the Illuminia Next Generation Sequencing (NGS) platform. See how it works and hear what Professor Mathias Uhlen from Stockholm's Royal Institute of Technolgy and Dr. Erika Assarsson (head of R&D at Olink) have to say about Explore and how it could help to accelerate proteomics research.
About the company
Olink Proteomics
Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing outstanding products and services for human protein biomarker discovery. Olink panels for precision proteomics help scientists make research decisions more quickly and confidently through robust, multiplex biomarker analysis. Its high-quality multiplex immunoassay panels help bring new insights into disease processes, improve disease detection, and contribute to a better understanding of biology.
Based on the pioneering research of Professor Ulf Landegren and his group at Uppsala University, Sweden, Olink was founded in 2004, The company has a successful history of developing molecular technologies, with a broad IP portfolio. Many of these have been commercialized through out-licensing to industry-leading partners such as Affymetrix, Life Technologies, and through the spin-out companies Qlinea and Halo Genomics (now part of Agilent). Olink sold its highly successful Duolink product line for in situ detection of proteins to Sigma-Aldrich in 2015.
Following a company reorganization in April, 2016, Olink Proteomics is focusing entirely on developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery.
